New workflow validated on Dynamic Devices Lynx® delivers scalable plasmid DNA extraction from Midi to Maxi-prep volumes ...

Collaborations with top automation, sequencing, & technology partners highlight Omega's commitment to advancing ...

Tevogen Bio secures an $8 million grant upon positive progress review, enhancing its AI-driven predictive modeling for immunotherapy. Tevogen Bio has announced that it will receive the remaining $8 ...

A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s machine learning ...

WALTHAM, Mass. and BEDFORD, Mass., Nov. 16, 2023/ PRNewswire/-- Q32 Bio Inc., a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Homology ...

Enhanced partnership brings leading investors into the review process for Startup Spotlight and Presenting Company ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird's fall from the one of the buzziest biotech ...

The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc.